Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 8 | 2019 | 248 | 1.050 |
Why?
|
| Hospitals | 2 | 2019 | 157 | 1.040 |
Why?
|
| Acute Lung Injury | 6 | 2018 | 18 | 0.770 |
Why?
|
| Enteral Nutrition | 6 | 2021 | 62 | 0.720 |
Why?
|
| Critical Illness | 5 | 2021 | 110 | 0.700 |
Why?
|
| Quality of Health Care | 2 | 2019 | 97 | 0.660 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 30 | 0.640 |
Why?
|
| Energy Intake | 6 | 2020 | 77 | 0.630 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2019 | 36 | 0.540 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 124 | 0.520 |
Why?
|
| Heart Valves | 1 | 2016 | 2 | 0.510 |
Why?
|
| Public Health | 2 | 2022 | 64 | 0.510 |
Why?
|
| Endocarditis | 1 | 2016 | 10 | 0.510 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 24 | 0.500 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 32 | 0.490 |
Why?
|
| Patient Safety | 1 | 2016 | 36 | 0.480 |
Why?
|
| Civil Defense | 1 | 2015 | 4 | 0.480 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 18 | 0.480 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.480 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2020 | 22 | 0.460 |
Why?
|
| Physicians | 2 | 2014 | 114 | 0.450 |
Why?
|
| Terminal Care | 1 | 2014 | 23 | 0.440 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 140 | 0.410 |
Why?
|
| Stroke | 1 | 2016 | 259 | 0.400 |
Why?
|
| Clinical Competence | 2 | 2014 | 207 | 0.390 |
Why?
|
| Nutritional Support | 4 | 2021 | 23 | 0.390 |
Why?
|
| Practice Guidelines as Topic | 3 | 2010 | 252 | 0.370 |
Why?
|
| Internship and Residency | 2 | 2014 | 208 | 0.360 |
Why?
|
| Humans | 28 | 2022 | 25967 | 0.340 |
Why?
|
| C-Reactive Protein | 3 | 2016 | 97 | 0.340 |
Why?
|
| Parenteral Nutrition | 4 | 2021 | 21 | 0.330 |
Why?
|
| Urinary Catheterization | 1 | 2009 | 6 | 0.320 |
Why?
|
| Chicago | 4 | 2016 | 898 | 0.320 |
Why?
|
| Catheter-Related Infections | 1 | 2009 | 21 | 0.320 |
Why?
|
| Urinary Tract Infections | 1 | 2009 | 31 | 0.310 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2005 | 3 | 0.240 |
Why?
|
| Male | 17 | 2020 | 14277 | 0.240 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 18 | 0.240 |
Why?
|
| Methotrexate | 1 | 2005 | 38 | 0.230 |
Why?
|
| Female | 16 | 2020 | 14734 | 0.230 |
Why?
|
| Adult | 10 | 2019 | 7662 | 0.230 |
Why?
|
| Lung | 1 | 2005 | 157 | 0.220 |
Why?
|
| Middle Aged | 11 | 2020 | 8772 | 0.200 |
Why?
|
| Health Information Exchange | 1 | 2022 | 4 | 0.200 |
Why?
|
| Hemorrhage | 2 | 2020 | 73 | 0.190 |
Why?
|
| United States | 2 | 2019 | 1989 | 0.180 |
Why?
|
| Aged | 10 | 2019 | 8732 | 0.180 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 21 | 0.170 |
Why?
|
| Critical Care | 2 | 2021 | 113 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2020 | 45 | 0.170 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2020 | 7 | 0.160 |
Why?
|
| Shock, Septic | 2 | 2010 | 59 | 0.160 |
Why?
|
| Retrospective Studies | 6 | 2019 | 3358 | 0.160 |
Why?
|
| Benchmarking | 1 | 2019 | 31 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 22 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2019 | 8 | 0.150 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 5 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2019 | 85 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 4641 | 0.140 |
Why?
|
| Glasgow Outcome Scale | 1 | 2016 | 1 | 0.130 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 29 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 27 | 0.130 |
Why?
|
| Cerebral Angiography | 1 | 2016 | 31 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 2016 | 99 | 0.120 |
Why?
|
| Risk Factors | 2 | 2016 | 2237 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2020 | 3399 | 0.120 |
Why?
|
| Patient Selection | 1 | 2016 | 190 | 0.120 |
Why?
|
| Hospital Mortality | 4 | 2019 | 134 | 0.110 |
Why?
|
| Time Factors | 2 | 2016 | 1391 | 0.110 |
Why?
|
| Nutritional Status | 3 | 2018 | 55 | 0.100 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 42 | 0.100 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 102 | 0.100 |
Why?
|
| Malnutrition | 1 | 2013 | 24 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 201 | 0.090 |
Why?
|
| APACHE | 3 | 2019 | 27 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2014 | 1107 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 332 | 0.090 |
Why?
|
| Dietetics | 1 | 2010 | 9 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2010 | 25 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2010 | 30 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2020 | 94 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2020 | 1701 | 0.080 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 21 | 0.080 |
Why?
|
| Dopamine | 1 | 2010 | 82 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2010 | 110 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 1941 | 0.080 |
Why?
|
| Nutritional Sciences | 1 | 2008 | 7 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 301 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 367 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 105 | 0.070 |
Why?
|
| Dietary Proteins | 2 | 2016 | 26 | 0.060 |
Why?
|
| Arsenicals | 1 | 2005 | 12 | 0.060 |
Why?
|
| Oxides | 1 | 2005 | 16 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2005 | 33 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 328 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 105 | 0.060 |
Why?
|
| Adolescent | 1 | 2009 | 2099 | 0.050 |
Why?
|
| Aging | 1 | 2013 | 1483 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 198 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2014 | 102 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 211 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 4 | 0.040 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2020 | 9 | 0.040 |
Why?
|
| Length of Stay | 2 | 2013 | 307 | 0.040 |
Why?
|
| Thyrotropin | 1 | 2020 | 49 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 339 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 251 | 0.040 |
Why?
|
| Veins | 1 | 2019 | 8 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2020 | 92 | 0.040 |
Why?
|
| Arteries | 1 | 2019 | 13 | 0.040 |
Why?
|
| Thyroxine | 1 | 2020 | 81 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 390 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 64 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 1806 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 603 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 571 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 147 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 12 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 132 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 34 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2013 | 31 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 202 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 52 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 449 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 473 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 433 | 0.020 |
Why?
|
| Cost Savings | 1 | 2010 | 31 | 0.020 |
Why?
|
| Resuscitation | 1 | 2010 | 11 | 0.020 |
Why?
|
| Tachycardia, Sinus | 1 | 2010 | 2 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 121 | 0.020 |
Why?
|
| Vasopressins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 57 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 25 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 58 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 160 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 326 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 17 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 137 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 252 | 0.020 |
Why?
|
| Cross Infection | 1 | 2010 | 297 | 0.020 |
Why?
|